Browsing Tag
WuXi Biologics
6 posts
WuXi Biologics wins EMA approval in Ireland as WuXiUP automation signals new chapter in global biologics manufacturing
WuXi Biologics secures EMA approval in Ireland and achieves WuXiUP automated continuous production, reinforcing global dual sourcing and biomanufacturing innovation.
August 18, 2025
Reynold Lemkins Group expands cross-border biotech investments with VISEN Pharmaceuticals (HKEX: 02561) IPO
Reynold Lemkins Group expands cross-border biotech strategy with VISEN Pharmaceuticals (HKEX: 02561) IPO, aligning capital with Asia’s AI-driven healthcare future.
June 10, 2025
Can WuXi Biologics’ new EffiX platform transform microbial expression? Here’s what to know
WuXi Biologics has introduced the EffiX platform, an advanced microbial expression system designed to enhance the production of…
March 4, 2025
WuXi Biologics and Toregem BioPharma to advance tooth regeneration treatment
WuXi Biologics (“WuXi Bio”), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has announced a strategic…
October 12, 2022
CANbridge Pharmaceuticals begins CAN103 phase 1/2 trial in Gaucher disease
CANbridge Pharmaceuticals said that it has dosed the first patient in a phase 1/2 trial of CAN103 in…
July 21, 2022
WuXi vaccine manufacturing facility in Ireland gets $3bn contract
Chinese CDMO WuXi Vaccines has signed a 20-year contract worth around $3bn with an undisclosed vaccine company to…
February 18, 2020